WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MCRB past revenue growth

How has MCRB's revenue growth performed historically?
Company
2,380.87%
Industry
82.96%
Market
15.15%
MCRB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MCRB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MCRB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MCRB earnings and revenue history

Current Revenue
$126.8M
Current Earnings
-$82.7M
Current Profit Margin
-65.2%

MCRB Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when MCRB announces earnings.

MCRB Return on Assets

Current Company
-22.4%
Current Industry
3.2%
MCRB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MCRB Return on Capital Employed

Current Company
-27.51%
Current Industry
-43.6%
MCRB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MCRB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MCRB$126.85M-$51.20M-$82.68M+32.03%N/A
LIFE$588.00k-$51.17M-$53.93M-48.70%N/A
RAPT$0.00-$114.48M-$118.05M-100.00%N/A
IMAB$3.82M-$195.33M-$202.72M-12.91%N/A
SEER$15.67M-$76.99M-$83.00M+303.56%N/A
View Top Biotech Stocks

Seres Therapeutics Earnings & Revenue FAQ

What were MCRB's earnings last quarter?

On Invalid Date, Seres Therapeutics (NASDAQ: MCRB) reported Q1 2024 earnings per share (EPS) of -$0.27, up 52.63% year over year. Total Seres Therapeutics earnings for the quarter were -$40.13 million. In the same quarter last year, Seres Therapeutics's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.

What was MCRB's earnings growth in the past year?

As of Q2 2024, Seres Therapeutics's earnings has grown year over year. Seres Therapeutics's earnings in the past year totalled -$82.68 million.

What was MCRB's revenue last quarter?

On Invalid Date, Seres Therapeutics (NASDAQ: MCRB) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Seres Therapeutics's revenue was -$522.00 thousand.

What was MCRB's revenue growth in the past year?

As of Q2 2024, Seres Therapeutics's revenue has grown 2,380.87% year over year. This is 2,297.91 percentage points higher than the US Biotechnology industry revenue growth rate of 82.96%. Seres Therapeutics's revenue in the past year totalled $126.85 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.